Legend Biotech seeks shareholder OK to add 19.1 million shares to RSU plan reserve
Reuters2026/08/18 20:03Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Legend Biotech seeks shareholder approval to amend its 2020 restricted shares plan, adding 19,100,000 ordinary shares to the issuance pool.
- Total reserve would rise to 45,100,000 ordinary shares from 26,000,000, effective Sept. 24, 2026 if adopted.
- The added reserve equals 4.9% of ordinary shares outstanding as of Aug. 17, 2026.
- Shares remaining for grant under the plan stood at 5,257,658 as of June 30, 2026.
- Separate equity overhang included 15,635,609 ordinary shares under outstanding awards; options carried a weighted-average exercise price of USD 10.32.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-005623), on August 18, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Targa Exploration closes C$3.19 million private placement of flow-through and hard-dollar units
Reuters•2026/09/12 00:43
Alpha Compute CFO Wesley Allen Levitt acquires 1,000 common shares worth $5,095.50
Reuters•2026/09/12 00:39
Alignment Healthcare CEO John E. Kao reports disposal of common shares worth $7.12 million
Reuters•2026/09/12 00:38
Halozyme CEO Helen Torley reports disposal of common shares worth USD 6.5 million
Reuters•2026/09/12 00:35
Crypto prices
MoreBitcoin
BTC
$77,304.15
+0.57%
Ethereum
ETH
$2,512.81
+2.31%
Tether USDt
USDT
$0.9998
+0.01%
BNB
BNB
$727.64
+2.27%
XRP
XRP
$1.36
+1.42%
USDC
USDC
$0.9999
-0.00%
Solana
SOL
$101.93
+3.02%
TRON
TRX
$0.3389
-0.53%
Hyperliquid
HYPE
$78.86
-0.10%
Zcash
ZEC
$1,161.22
+7.10%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now